Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Hematological Oncology
|
December 1, 1996
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas
C Corti, C Theodore, C Bayle, et al.
Journal of the American College of Surgeons
|
November 11, 1998
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients
D Elias, A Cavalcanti de Albuquerque, P Eggenspieler, et al.
Cancer
|
November 1, 1989
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide
C Theodore, M Azab, J P Droz, et al.
Cancer
|
August 1, 1988
Prognostic factors in gestational trophoblastic tumors. A multivariate analysis
M B Azab, M H Pejovic, C Theodore, et al.
Bulletin Du Cancer
|
January 1, 1989
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]
S Culine, M Azab, F Pietri, et al.
Presse Medicale (Paris, France : 1983)
|
July 7, 1990
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]
V Ribrag, J P Droz, C Bouleuc, et al.
Oncology
|
January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinoma
P Rougier, H Ammarguellat, M Ghosn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2008
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
C Theodore, I Skoneczna, I Bodrogi, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors
J P Droz, V Ribrag, M Ghosn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2006
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
C Theodore, F Bidault, N Bouvet-Forteau, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Hematological Oncology
|
December 1, 1996
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas
C Corti, C Theodore, C Bayle, et al.
Journal of the American College of Surgeons
|
November 11, 1998
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients
D Elias, A Cavalcanti de Albuquerque, P Eggenspieler, et al.
Cancer
|
November 1, 1989
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide
C Theodore, M Azab, J P Droz, et al.
Cancer
|
August 1, 1988
Prognostic factors in gestational trophoblastic tumors. A multivariate analysis
M B Azab, M H Pejovic, C Theodore, et al.
Bulletin Du Cancer
|
January 1, 1989
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]
S Culine, M Azab, F Pietri, et al.
Presse Medicale (Paris, France : 1983)
|
July 7, 1990
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]
V Ribrag, J P Droz, C Bouleuc, et al.
Oncology
|
January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinoma
P Rougier, H Ammarguellat, M Ghosn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2008
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
C Theodore, I Skoneczna, I Bodrogi, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors
J P Droz, V Ribrag, M Ghosn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2006
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
C Theodore, F Bidault, N Bouvet-Forteau, et al.
Page
of 14